Clinical Trial Update: Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract [Phase 2]

View source ↗

Summary

Phase 2 trial investigating cetuximab for precancerous lesions of the upper aerodigestive tract; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Precancerous Condition

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Head and Neck Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED | Results posted: 2020-03-12